Scientific communities are establishing standardized naming systems across multiple fields—from radiopharmaceutical therapies and immune cell classifications to virus taxonomy and liver disease categories. Researchers are publishing new nomenclature guidelines to create shared language and clarity where terminology has been fragmented or inconsistent.
·Radiopharmaceutical researchers developing unified nomenclature for treating neuroendocrine tumors and prostate cancer
·New T cell nomenclature guidelines published to standardize immune cell classification beyond traditional subsets
·Virus classification systems being refined to establish consistent international naming conventions
·Steatotic liver disease classification struggling with real-world applicability due to multifactorial phenotypes
·GPCR signaling field clarifying terminology for kinases and arrestins across dependent and independent pathways
drawn from Journal of Nuclear Medicine, Nature, ASM Journals, British Pharmacological Society | Journals · updated 22d ago